University of Southampton
Recognition of viral peptides by inhibitory and activating killer immunoglobulin-like receptors
Abstract
dc:description.abstract<br/>Background and Aim: Natural killer (NK) cells are lymphocytes from the innate immunity<br/>critical in the control of viral infections. NK cell functions against viruses are largely regulated<br/>by the interaction between Killer Immunoglobulin-like receptors (KIR) and Major<br/>Histocompatibility Complex class I (MHC-I):peptide ligands. Recently, our group reported<br/>that highly conserved peptides derived from viruses of the family Flaviviridae bind the HLAC*<br/>0102 allele and together induce strong KIR2DS2-mediated NK cell functions. Given the<br/>enormous allelic diversity of the MHC-I locus, this thesis aimed to investigate the ability of<br/>Flaviviridae-derived peptides to bind different Human Leukocyte Antigen C (HLA-C) alleles<br/>and to activate NK cells through engagement with KIR2DS2.<br/>Methods: An in vitro co-culture system using different combinations of target and effector<br/>cell lines was optimized. As target cells, we used Transporter-associated with Antigen<br/>Processing (TAP)-deficient or TAP-competent cells expressing different HLA-C alleles and<br/>presenting exogenous or endogenous viral peptides containing the AT motif and derived<br/>from the non-structural 3 (NS3) proteins of Hepatitis C virus (HCV; LNPSVAATL),<br/>Dengue/Zika virus (DENV/ZIKV; IVDLMCHATF), Yellow Fever virus (YFV; VIDAMCHATL)<br/>and West Nile/Japanese Encephalitis virus (WNV/JEV; IVDVMCHATL). As effector cells,<br/>NKL cell lines or primary NK cells expressing inhibitory KIR2DL2 or activating KIR2DS2<br/>receptors, were used. Activation of NK cells to different targets was determined by<br/>assessing NK cell cytotoxicity, degranulation and inhibition of viral replication.<br/>Results: Huh-7 cells expressing the HCV replicon and presenting endogenous viral<br/>peptides in the context of HLA-C*0304 or HLA-C*0802 were strongly recognized by the<br/>Natural Killer Cell Leukaemia (NKL) cell line expressing KIR2DS2; this effect was<br/>independent of LNPSVAATL peptide. TAP-deficient 721.221 cells expressing HLA-C*0802<br/>or HLA-C*0501 and loaded with IVDLMCHATF peptide strongly bound KIR2DS2-PE<br/>tetramers; however only TAP-competent 721.221 cells expressing HLA-C*0802 and<br/>endogenously presenting DENV/NS3-derived peptides induced strong NK cell effector<br/>functions through canonical interaction with KIR2DS2. Finally, 721.221 cells co-expressing<br/>HLA-C*0802 and IVDLMCHATF peptide generated robust NK cell degranulation and<br/>cytotoxic activity. Unlike LNPSVAATL, IVDLMCHATF peptide is predicted to have a broad<br/>HLA-C specificity.<br/>Conclusion: This research identified a Flaviviral peptide carrying the highly conserved<br/>“MCHAT” motif (IVDLMCHATF) that in complex with HLA-C*0802 specifically interacted<br/>with KIR2DS2 leading to robust NK cell effector functions. This is the first viral peptide<br/>defined that binds an activating KIR and more than one HLA-C type. These data imply that<br/>Flaviviruses are credible drivers of the evolution of KIR2DS2.
Degree
thesis:*- Name dc:type.qualificationname
- Ph.D.
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- University of Southampton
- Year dc:date.issued
- 2020
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Bastidas Legarda, Leidy Yamile
- Advisor dc:contributor.advisor
-
- Khakoo, Salim
- ORCID person:identifier.orcid
Rights
- Language dc:language
- English, eng